NewAmsterdam Pharma Company N.V. Stock Börse Stuttgart
Equities
KH6
NL00150012L7
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
18 EUR | +0.56% | +14.01% | +80.81% |
Sales 2024 * | 8.64M 9.24M | Sales 2025 * | 6.31M 6.75M | Capitalization | 1.66B 1.78B |
---|---|---|---|---|---|
Net income 2024 * | -210M -225M | Net income 2025 * | -139M -149M | EV / Sales 2024 * | 193 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 264 x |
P/E ratio 2024 * |
-7.91
x | P/E ratio 2025 * |
-12.3
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.29% |
Latest transcript on NewAmsterdam Pharma Company N.V.
1 week | +14.01% | ||
Current month | +8.48% | ||
1 month | +4.68% | ||
3 months | -11.39% | ||
6 months | +84.54% | ||
Current year | +80.81% |
Date | Price | Change |
---|---|---|
24-06-27 | 18 | +0.56% |
24-06-26 | 17.9 | +0.56% |
24-06-25 | 17.8 | +8.54% |
24-06-24 | 16.4 | -2.38% |
24-06-21 | 16.8 | +7.01% |
Delayed Quote Börse Stuttgart, June 27, 2024 at 06:28 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.49% | 122B | |
+21.73% | 115B | |
+22.04% | 26.64B | |
-21.81% | 19.91B | |
-16.87% | 16.32B | |
-18.81% | 15.49B | |
-44.74% | 15.52B | |
+62.72% | 14.83B | |
+3.09% | 13.67B |
- Stock Market
- Equities
- NAMS Stock
- KH6 Stock